Capital Fund Management S.A. Has $8.91 Million Holdings in Inspire Medical Systems, Inc. $INSP

Capital Fund Management S.A. grew its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 44.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 68,663 shares of the company’s stock after purchasing an additional 21,021 shares during the quarter. Capital Fund Management S.A. owned about 0.23% of Inspire Medical Systems worth $8,910,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. State Board of Administration of Florida Retirement System raised its stake in Inspire Medical Systems by 1.8% during the second quarter. State Board of Administration of Florida Retirement System now owns 31,667 shares of the company’s stock worth $4,109,000 after buying an additional 557 shares during the last quarter. Atika Capital Management LLC boosted its position in Inspire Medical Systems by 0.8% during the second quarter. Atika Capital Management LLC now owns 161,900 shares of the company’s stock valued at $21,010,000 after acquiring an additional 1,300 shares during the last quarter. Choreo LLC grew its holdings in Inspire Medical Systems by 9.8% during the 2nd quarter. Choreo LLC now owns 1,877 shares of the company’s stock worth $244,000 after acquiring an additional 168 shares during the period. Northwest & Ethical Investments L.P. raised its position in shares of Inspire Medical Systems by 3.8% in the 2nd quarter. Northwest & Ethical Investments L.P. now owns 5,940 shares of the company’s stock worth $771,000 after acquiring an additional 216 shares in the last quarter. Finally, Rhenman & Partners Asset Management AB lifted its stake in shares of Inspire Medical Systems by 90.6% in the 2nd quarter. Rhenman & Partners Asset Management AB now owns 30,500 shares of the company’s stock valued at $3,958,000 after purchasing an additional 14,500 shares during the period. 94.91% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on INSP. Wells Fargo & Company raised Inspire Medical Systems from an “equal weight” rating to an “overweight” rating and decreased their target price for the stock from $101.00 to $90.00 in a research note on Tuesday, November 4th. Evercore ISI cut their price target on Inspire Medical Systems from $150.00 to $125.00 and set an “outperform” rating on the stock in a report on Tuesday, October 7th. JPMorgan Chase & Co. lowered their price objective on shares of Inspire Medical Systems from $110.00 to $82.00 and set a “neutral” rating for the company in a research note on Tuesday, November 4th. UBS Group set a $89.00 target price on shares of Inspire Medical Systems and gave the company a “neutral” rating in a research report on Monday, September 22nd. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Inspire Medical Systems in a report on Wednesday, October 8th. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $134.88.

Inspire Medical Systems Trading Down 1.9%

NYSE INSP opened at $124.90 on Friday. The company has a fifty day simple moving average of $84.35 and a 200 day simple moving average of $105.28. Inspire Medical Systems, Inc. has a 12-month low of $70.77 and a 12-month high of $216.01. The company has a market cap of $3.63 billion, a P/E ratio of 84.97, a PEG ratio of 13.48 and a beta of 1.14.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.53. The firm had revenue of $224.50 million for the quarter, compared to the consensus estimate of $220.39 million. Inspire Medical Systems had a net margin of 5.05% and a return on equity of 9.41%. The business’s revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.60 earnings per share. Sell-side analysts predict that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Inspire Medical Systems declared that its board has initiated a share repurchase plan on Monday, August 11th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to buy up to 8.6% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its shares are undervalued.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.